Trial Profile
The Diurnal and Nocturnal Effect of Simbrinza and Timolol on Intraocular Pressure and Ocular Perfusion Pressure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2016
Price :
$35
*
At a glance
- Drugs Brimonidine/brinzolamide (Primary) ; Timolol
- Indications Exfoliation syndrome; Ocular hypertension; Open-angle glaucoma; Pigmentary glaucoma
- Focus Therapeutic Use
- 10 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 02 Nov 2015 Planned End Date changed from 1 Oct 2015 to 1 Oct 2016 as reported by ClinicalTrials.gov record.
- 02 Nov 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Oct 2016 as reported by ClinicalTrials.gov record.